Magnetic Resonance Imaging of Brain Development in Attention Deficit Hyperactivity Disorder
1 other identifier
observational
400
1 country
1
Brief Summary
The primary purpose of this study is to investigate brain whether ADHD represents a disruption or a delay of brain development. Children and adolescents both with and without ADHD are asked to participate in several MRI sessions, two years apart. This will allow us to chart brain development over time, both in typical development and ADHD, and therefore to address whether ADHD represents a disruption or a delay of typical brain development.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2005
CompletedFirst Submitted
Initial submission to the registry
August 31, 2005
CompletedFirst Posted
Study publicly available on registry
September 2, 2005
CompletedMarch 20, 2007
March 1, 2007
August 31, 2005
March 18, 2007
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Aged 6 - 18 years at initial MRI
- DSM-IV (APA, 1994) diagnosis of ADHD, according to DISC interview
- Scores in the clinical range on the Child Behavior Checklist (CBCL) and Teacher Rating Form(TRF)
- No DSM-IV (APA, 1994) diagnosis, according to DISC interview
- No scores in the clinical range on the Child Behavior Checklist (CBCL) and Teacher Rating Form (TRF)
You may not qualify if:
- IQ \< 70
- Major illness of the cardiovascular, the endocrine, the pulmonal or the gastrointestinal system
- Presence of metal objects in or around the body (pacemaker, dental braces)
- History of or present neurological disorder
- For individuals over 12 years of age: legal incompetence, defined as the obvious inability to comprehend the information that is presented by the investigator and is outlined in the Information letter and on which the decision to participate in the study is to be based
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- UMC Utrechtlead
Study Sites (1)
Dept. of Child and Adolescent Psychiatry, UMC Utrecht
Utrecht, Netherlands
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah Durston, Ph.D.
Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht
- STUDY CHAIR
Herman van Engeland, M.D. Ph.D.
Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 31, 2005
First Posted
September 2, 2005
Study Start
August 1, 2005
Last Updated
March 20, 2007
Record last verified: 2007-03